iRhythm Technologies Inc (IRTC)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$145.00

Buy

$220.00

arrow-down$-0.27 (-0.16%)

Prices updated at 12 Dec 2025, 22:56 EST

Prices minimum 15 mins delay

Prices in USD

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Abhijit Y. Talwalkar

CEO

Mr. Quentin S. Blackford

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

2,000

Head office

699 8th Street

San Francisco

United States

94103

+1 415 632-5700

investors@irhythmtech.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Karen K. McGinnis, C.P.A. Independent Director	-
Mr. Kevin O’Boyle Independent Director	-
Mr. Chad Patterson Chief Commercial Officer and Product Officer	0.52m
Mr. Abhijit Y. Talwalkar Chairman of the Board	0.11m
Mr. Bruce G. Bodaken Independent Director	0.07m
Ms. Karen L. Ling Independent Director	0.07m
Mr. Quentin S. Blackford Director, President and Chief Executive Officer	0.74m
Mr. Brian B. Yoor Independent Director	0.06m
Dr. Cathleen Noel Bairey Merz, M.D. Independent Director	0.06m
Ms. Sumi Shrishrimal Executive Vice President and Chief Risk Officer	-
Mr. Daniel G. Wilson Chief Financial Officer	0.46m
Mr. Patrick M. Murphy Chief Business Officer and Chief Legal Officer	0.51m
Mr. Marc Rosenbaum Senior Vice President, Finance and Chief Accounting Officer	-
Dr. Minang Turakhia, M.D.,M.S. Chief Medical Officer, Chief Scientific Officer and Executive Vice President, Product Innovation	0.51m
Mr. Mervin Smith Executive Vice President, Business Operations	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Tudor Investment Corp Et AL	20,000,000
Vanguard Group Inc	3,235,660
BlackRock Inc	2,875,476
Artisan Partners LP	2,780,259
Artisan Partners Limited Partnership	2,567,513

Director dealings

Date chevron-l-regular chevron-r-regular	Action
04 Nov 2024	-
15 Sep 2024	-
09 Aug 2024	-
02 Aug 2024	-
02 Jul 2024	-
03 Jun 2024	-
03 Jun 2024	-
31 May 2024	-
04 Nov 2024	-
02 Aug 2024	-
31 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
29 May 2024	-
04 Mar 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.